EUVIMEDEUVIMED entdecken
Crossref

A Robust Methodological Framework for Generating Whole‐Brain and Cortical Organoids From Diverse Healthy‐ and Patient‐Derived Induced Pluripotent Stem Cell Lines

Tara Fournier, Eugenia Pugliese, Benjamin Montagne, Chiara Cimmaruta, Miria Ricchetti

Biology of the Cell · 2026-02 · 118 (2)

DOI: 10.1111/boc.70051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of the Cell, online erschienen am 28.02.2026. Verfasst von Tara Fournier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental and Stem Cell Biology, Molecular Mechanisms of Pathological and Physiological Ageing, UMR3738 CNRS, Institut Pasteur, Par…. Hauptthemen laut MEDLINE: Organoids, Induced Pluripotent Stem Cells, Brain, Cerebral Cortex. Die Arbeit nennt 35 Literaturangaben. Gefördert von: ANR, CNES, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patient‐derived neural organoids (NOs) have emerged as powerful tools for modeling human neurodevelopmental disorders, especially when animal models are unavailable or fail to recapitulate human‐specific cortical development. However, significant variability in differentiation potential, even among healthy donor lines, and especially in fragile patient‐derived induced pluripotent stem cells (iPSCs), poses major methodological challenges. Protocols that succeed in one line may fail in others, leading to poor organoid formation, reduced growth, impaired neuroepithelial patterning, or complete failure to generate neural tissues.

Methods

By systematically comparing multiple published protocols, we identified key sources of variability and ultimately developed optimized protocols for generating both whole‐brain (WB) and cortical organoids (CO) from human iPSCs (hiPSCs), including lines from progeroid Cockayne syndrome patients.

Results

Through iterative refinement of critical parameters, including cell seeding density, Matrigel incorporation, and timing and type of pathway inhibition, we achieved consistent organoid growth and structural organization across all tested lines. The resulting pipeline is adaptable and can be further tailored for newly derived or particularly challenging hiPSC lines.

Conclusion

Collectively, this methodological framework enables robust and reproducible generation of NOs from genetically diverse hiPSC sources, providing a reliable platform for studying human neurodevelopment and disease mechanisms in progeroid and other patient‐specific contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsInduced Pluripotent Stem CellsBrainCerebral CortexHumansCell DifferentiationNeurodevelopmentCell Culture TechniquesCell Line

Stichwörter der Autor:innen

TRIPLE‐Icortical organoidshiPSCspatterning protocolsprogeroid diseasewhole‐brain organoids

Autor:innen und Institutionen

  • Department of Developmental and Stem Cell Biology, Molecular Mechanisms of Pathological and Physiological Ageing, UMR3738 CNRS, Institut Pasteur, Paris, France.
  • Collège Doctoral, Sorbonne Université, Paris, France.

Förderung

  • ANR
  • CNES
  • Agence Nationale de la Recherche
  • Centre National d’Etudes Spatiales

Zitieren

APA

Fournier, T., Pugliese, E., Montagne, B., Cimmaruta, C., & Ricchetti, M. (2026). A Robust Methodological Framework for Generating Whole‐Brain and Cortical Organoids From Diverse Healthy‐ and Patient‐Derived Induced Pluripotent Stem Cell Lines. Biology of the Cell, 118(2). https://doi.org/10.1111/boc.70051

Vancouver

Fournier T, Pugliese E, Montagne B, Cimmaruta C, Ricchetti M. A Robust Methodological Framework for Generating Whole‐Brain and Cortical Organoids From Diverse Healthy‐ and Patient‐Derived Induced Pluripotent Stem Cell Lines. Biology of the Cell. 2026;118(2). doi:10.1111/boc.70051

BibTeX
@article{Fournier2026,
  author = {Fournier, Tara and Pugliese, Eugenia and Montagne, Benjamin and Cimmaruta, Chiara and Ricchetti, Miria},
  title = {A Robust Methodological Framework for Generating Whole‐Brain and Cortical Organoids From Diverse Healthy‐ and Patient‐Derived Induced Pluripotent Stem Cell Lines},
  journal = {Biology of the Cell},
  year = {2026},
  volume = {118},
  number = {2},
  doi = {10.1111/boc.70051}
}
Kostenlos starten →